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Abstract (200 words) 
Exploring the tendon proteome is a challenging but important task for understanding the 
mechanisms of physiological/pathological processes during ageing and disease and for the 
development of new treatments. Several extraction methods have been utilised for tendon mass 
spectrometry, however different extraction methods have not been simultaneously compared. In 
the present study we compared protein extraction in tendon with two chaotropic agents, guanidine 
hydrochloride (GnHCl) and urea, a detergent, RapiGestTM, and their combinations for shotgun mass 
spectrometry.  
An initial proteomic analysis was performed following urea, GnHCl, and RapiGestTM extraction of 
equine superficial digital flexor tendon (SDFT) tissue. Subsequently, another proteomic analysis was 
performed following extraction with GnHCl, RapigestTM, and their combinations. Between the two 
chaotropic agents, GnHCl extracted more proteins, whilst a greater number of proteins were solely 
identified after RapigestTM extraction. Protein extraction with a combination of GnHCl followed by 
RapiGestTM on the insoluble pellet demonstrated, after label-free quantification, increased 
abundance of identified collagen proteins and low sample to sample variability. In contrast, GnHCl 
extraction on its own showed increased abundance of identified proteoglycans and cellular proteins. 
Therefore, the selection of protein extraction method for tendon tissue for mass spectrometry 
analysis should reflect the focus of the study.   
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Significance of the study  
The ability to produce robust and effective methodologies in mass spectrometry-based proteomic 
sample preparation will be invaluable for future studies in tendon enabling its comprehensive 
proteomic characterisation and helping to identify potential target areas for diagnostics/therapeutic 
purposes. In this study, we determine the first comparison between chaotropic- and detergent-
based work-flows for tendon sample preparation for mass spectrometry analysis.  
1 1 Introduction 
Tendons are dense connective tissues that perform key roles in the musculoskeletal system. They 
serve primarily to transfer the pull of muscles to bone [1] but also engage in locomotion by 
transferring the forces generated by the muscles to the skeleton [2]. Injuries to tendons are common 
in humans as well as other species such as the horse [3, 4]. More than 30 million tendon injuries  per 
year are reported worldwide in humans [5] and represents a major health care burden [6]. Among 
tendons, the rotator cuff, Achilles, and patellar tendons are the most commonly affected in humans 
[7], whilst in the horse the superficial digital flexor tendon (SDFT) is most commonly injured [4]. Risk 
factors such as repetitive loading [8], chronic inflammation [9], genetic factors [10], and ageing [11] 
have been demonstrated to play a role in tendon injury in both humans and the horse.  
Mass spectrometry (MS) analysis is becoming an attractive tool for tendon proteomic profile 
characterisation, with studies outlining the differences in disease [9], with ageing [11] , at different 
anatomical compartement [12], as well as differences between tendon and ligament and tissues 
engineered tissues [13]. However, a robust and reproducible protein extraction method specific for 
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tendon tissue is lacking. The use of proteomic techniques will allow tendon protein profiles and 
patterns to be defined under different conditions to obtain a clearer insight into tendon 
composition, which will have an impact for cell based therapies and tissue engineering strategies in 
tendon disease. 
Tendons are composed of water, a small population of cells (predominately tenocytes) and 
extracellular matrix (ECM) consisting predominately of collagens (I, III, V, VI, XII, XIV) [8, 14], 
proteoglycans [15], glycoproteins [14], and elastin [16]. Tendon protein extraction can be 
challenging due to its collagen-rich composition 
which exhibits high intermolecular cross-linking [17] that accumulates with ageing and therefore 
makes it resistant to extraction [11]. Chaotropic agents [11, 13], surfactants [12, 18, 19], and other 
agents such as cyanogen bromide and proteases [20] have been used for tendon protein extraction 
for MS analysis. However, to date no study has compared different extraction methods for tendon.  
Guanidine-HCl (GnHCl) is one of the most efficient chaotropic agents [21] and has been used for 
protein extraction in ECM-rich tissues such as bone [22, 23], cartilage [24, 25],  ligament and tendon 
[13, 20, 26]. Urea is another chaotropic agent that has been widely used and is efficient for cell and 
tissue lysis [27-29]. Chaotropic agents exert their function by extracting  non-covalently bound ECM 
and cellular proteins leaving behind an insoluble fraction [11, 13, 25]. Another extraction technique 
that has recently been used in tendon proteomic studies is the surfactant RapiGestTM (Waters) [12, 
18], which was shown to increase protein identification [25, 30].  
The aim of this study was 1) to compare differences between two different chaotropic agents and a 
detergent based work-flow for label-free (LF) MS-based analysis in tendon and  2)  to identify 
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whether combining a chaotropic agent and a detergent for protein extraction could increase the 
protein coverage in tendon.  
2 2 Material and Methods  
All chemicals were supplied by Sigma–Aldrich, Dorset, UK unless otherwise stated. 
2.1 Tissue collection and preparation 
Forelimbs, distal to the carpus, were collected from middle-aged horses (n=3, aged 12.3 ± 1.15, 
mean ± SD) from a commercial equine abattoir. Ethical approval is not required for samples 
collected as by-products of the agricultural industry according to the Animal (Scientific Procedures) 
Act 1986, Schedule 2. SDFTs were collected and a 2 cm sample was dissected from the mid-
metacarpal region. Only tendons that had no evidence of previous tendon injury at post-mortem 
examination were included in the study.  All samples were snap-frozen in liquid nitrogen and stored 
at -80°C until required.  
Samples for protein extraction were homogenised using a dismembrator (B.Braun Biotech. 
International, Germany), split into three or four aliquots of approximately 20 mg and deglycolysated 
with 1 U/ml chondroitinase ABC for six hours at 37°C [13] prior to protein extraction.  
2.2  Comparison between GnHCl, urea and RapiGestTM extraction 
2.2.1 GnHCl protein extraction   
0.5 mL of GnHCl extraction buffer (4 M GnHCl, 65 mM dithiothreitol (DTT), 50 mM sodium acetate 
and protease inhibitors (complete Protease Inhibitors, EDTA-free, Roche Applied Science) was added 
to the samples. Each sample was then sonicated on ice (3 cycles of 10s each at 40% output) on an 
ultrasonic processor followed by incubation at 4°C on a shaker for 48 hours. After centrifugation at 
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15,000 rpm at 4°C for 15 minutes, the supernatant (soluble fraction) was collected and stored at -
20°C until further analysis. 
2.2.2 Urea protein extraction  
0.5 mL of urea extraction buffer (7 M Urea, 0.15 M Sodium Chloride, 50 mM tris hydrochloride and 
protease inhibitors, pH 6.5) was added to each sample followed by sonication, centrifugation, and 
supernatant collection as described in Section 2.2.1. 
2.2.3 RapiGestTM protein extraction 
250 µL 50 mM ammonium bicarbonate (Ambic) was added to each sample before sonication 
(Section 2.2.1). The samples were then topped up with 250 µL 0.2% RapiGestTM in 50 mM Ambic and 
heated at 80oC for 10 minutes. A second heating step at 60oC for one hour was performed after the 
samples were left to cool down at room temperature for 10 minutes. Following the second heating 
step, the samples were spun down at maximum speed for 10 minutes and the supernatant was 
collected. The remaining pellet was topped up with 20 µL RapiGestTM (0.1%, in 50 mM Ambic) and 
heated at 60oC for 10 minutes before centrifugation at maximum speed for 10 minutes. The 
supernatant was collected and added to the previously collected supernatant (soluble fraction). 
2.3 Comparison between GnHCl and RapiGestTM extraction and their 
combinations 
A schematic representation of the experimental workflow for the comparison of GnHCl and RapiGest 
extraction methods and their combinations is presented in Figure 1B. 
2.4.1 GnHCl and Rapigest combined protein extraction  
450 µL GnHCl and RapiGestTM extraction buffer (0.1% RapiGestTM in guanidine extraction buffer) was 
added to each sample before sonication (Section 2.2.1). The samples were then incubated on a 
www.proteomics-journal.com Page 7 Proteomics 
 
 
This article is protected by copyright. All rights reserved. 
7 
 
shaker for 48 hours at 4°C followed by heating at 80oC for 10 minutes. A second heating step at 60oC 
for one hour was performed after the samples were left to cool down at room temperature for 10 
minutes. Following the second heating step, the samples were spun down at maximum speed for 10 
minutes at room temperature, and the supernatant was collected. The remaining pellet was topped 
up with 20 µL RapiGestTM (0.1%, in 50 mM Ambic), heated at 60oC for 10 minutes, centrifuged, and 
the supernatant collected as described in Section 2.2.3. 
2.4.2 GnHCl extraction followed by RapiGestTM extraction on the insoluble pellet 
250 µL GnHCl extraction buffer was added to each sample before sonication (Section 2.2). The 
samples were then incubated on a shaker for 48 h at 4°C, centrifuged and the soluble fraction 
collected (Section 2.2.1). Subsequently, the remaining pellet was washed three times with 100 µL 50 
mM Ambic. The supernatant from the first wash was collected and added to the soluble fraction 
(additional washes were discarded). 250 µL 0.2% RapiGestTM was added to the insoluble pellet and 
the RapiGestTM extraction steps undertaken as described in Section 2.2.3.  
The same protocol was used when comparing different concentrations of RapiGestTM (0.1%, 0.2% 
and 0.4%) following GnHCl extraction. 
2.7 In-solution trypsin digestion and LC-MS/MS 
Prior to trypsin digestion the protein concentration of each soluble fraction was calculated using the 
PierceTM  660 nm protein assay and samples were analysed by 1D-SDS-PAGE gel electrophoresis to 
assess gross qualitative differences in protein profiles. In-solution tryptic digest was carried out on 
10 µl of stratacleanTM resins (Agilent Genomics, UK) on 100 µg protein for each sample. Prior to 
digest Strataclean beads were washed 3x of 25mM ambic. In-solution tryptic digestion of protein 
samples was carried out following sequential reduction and alkylation in 3 mM DTT (60 °C for 10 
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min) and then 9 mM iodoacetamide (30 min in the dark at room temperature) with trypsin at a ratio 
of 1:25 protein: trypsin ratio overnight at 37 °C. Detergent inactivation was then assumed by 
incubating for 45 min at 37 °C with trifluoroacetic acid (VWR International, UK) to a final 
concentration of 0.5% (v/v). Following centrifugation (10 min, 15,000 × g) the soluble phase was 
retrieved [31]. LC-MS/MS was performed using an Ultimate 3000 nano system (Dionex/Thermo 
Fischer) coupled online to a Q-Exactive Quadrupole-Orbitrap mass spectrometer. 50 ng tryptic 
peptides from randomised samples was loaded onto the column on a one hour gradient with an 
inter-sample 30 minutes blank [26].  
2.8 Proteomic data analysis 
MS data were analysed for protein identification using PEAKS (version, 7, Bioinformatics Solution, 
Waterloo, Canada) and label-free (LF) quantification was performed with ProgenesisQI  LC-MS 
(Waters, Elstree Hertfordshire, UK) software [26]. The MS data has been deposited in PRIDE 
database (http://www.ebi.ac.uk/pride/) at the European Bioinformatics Institute under the 
accession number PXD004453.   
2.8.1 Protein identification  
Raw MS/MS files were imported into PEAKS studio 7 (Bioinformatics solution, 7, Waterloo, Canada) 
and searched against the UniHorse database (http://www.uniprot.org/proteomes/). Search 
parameters used were: 10 ppm peptide mass tolerance and 0.01 Da fragment mass tolerance;  
precursor mass search type, monoisotopic; enzyme, trypsin; max missed cleavage, 1; nonspecific 
cleavage, 1; fixed modification;  carbamidomethylation; variable modifications, methionine 
oxidation and  hydroxylation; variable PTMs per peptide, 3. Search results were adjusted to 1% FDR 
at peptide spectrum matches, –10lgp > 20, unique peptides ≥ 2, and confidence score ≥ 50%.  
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2.8.3 GO and protein network analysis 
Identified proteins for each extraction method and were classified into ECM categories according to 
Matrisome Project [32] and for cellular compartments according through PANTHER (protein analysis 
through evolutionary relationships) [33].  
2.8.2 LF quantification  
LF quantitative analysis between different extraction methods was performed using ProgenesisQI LC-
MS as previously described [26]. Briefly, the top 5 spectra for each feature were exported from 
ProgenesisQI
 
and utilized for peptide identification with a PEAKS studio 7 searching against the 
UniHorse database. Search parameters used were as decribed in Section 2.8.1 and were re-imported 
into ProgenesisQI. Differentially abundant proteins (p <0.05, fold change > 2) in each group were 
categorised through PANTHER Classification System.  
2.8.3 Statistical analysis  
Statistical analysis was performed on protein concentration measurements using one-way analysis of 
variance (ANOVA) with Bonferroni post-hoc test using Graphpad Prism (version 6, Graphpad 
Sofware, La Jolla California, USA).  Statistical analysis for LF quantification was performed by 
ProgenesisQI software on all detected features using transformed normalized abundance for ANOVA. 
Identified proteins with two or more peptides, greater than 2 fold abundance and with a p-value 
adjusted to FDR p<0.05 were considered as significantly differentially abundant. 
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3 3 Results  
3.1  A higher number of proteins were identified with GnHCl in comparison to 
Urea and RapiGestTM extraction methods    
A total of 249, 186 and 123 proteins were identified with GnHCl, Urea, and RapiGestTM extraction 
methods respectively. Between all three extraction methods 62 proteins were found to be common 
(Figure 1A). Chaotropic agents identified 139  proteins in common, but a higher number of total and 
unique proteins were indentified in GnHCl compared to Urea (Figure 1A). RapiGestTM extraction gave  
less common identified proteins with GnHCl (74) and with urea (67), whilst having more unique 
proteins than urea (Figure 1A). Based on these results, a combination of GnHCl and RapiGestTM was 
investigated (Figure 1B).  All identified proteins in the three methods are provided in Supplementary 
Table 1.  
3.2  Improved extraction efficiency and less disparity was found with the 
extraction method of GnHCl followed by RapiGestTM on the insoluble pellet 
 1D SDS-PAGE analysis of GnHCl and RapiGestTM extraction and their combinations displayed 
variability in protein profiles with the RapiGestTM extraction showing an absence of high molecular 
proteins compared to the other methods (Figure 2A). GnHCl followed by RapiGestTM extraction 
yielded a higher protein concentration (13.9 ± 1.2 µg/mg weight) with the least variability between 
the samples in comparison to the other three extraction methods (Figure 2B). A total number of 229, 
112, 138, and 203 proteins were identified for GnHCl, RapiGestTM, GnHCl and RapiGestTM and GnHCl 
followed by RapiGestTM respectively (Figure 2C).  The GnHCl followed by RapiGest method gave the 
most identified unique proteins whilst RapiGestTM had the least (Figure 2C). Protein composition 
with GnHCl and GnHCl followed by RapiGestTM extracts revealed a similar percentage of cell 
associated proteins (49%) which was higher than for the other two methods. Following RapiGestTM 
extraction, a higher percentage of proteins (39%) associated to the matrisome was identified being 
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predominantly core matrisomal collagens (Figure 2D). All identified proteins in the four methods are 
provided in Supplementary Table 2.  
The ProgenesisQI quality control report demonstrated less inter-sample variability in percentage of 
peptide ions and number of peptides and proteins for the GnHCl followed by RapiGestTM extraction 
method (Figure 3A-C). This finding was supported by the protein PCA plot which demonstrated that 
samples from the GnHCl followed by RapiGestTM extraction method were grouped closer together 
(Figure 3D). LF analysis demonstrated a set of 170 proteins within the four extraction methods with 
a fold change > 2, unique peptides ≥ 2, and FDR adjusted p < 0.05.  From the proteins that were most 
abundant in the GnHCl extract, 65% were cellular and intracellular associated, with the remaining 
28% and 6% identified as ECM and membrane bound proteins respectively (Figure 3E). In contrast, 
from the proteins that were most abundant after RapiGestTM extraction, a considerably higher 
percentage were ECM associated proteins (78%) and a smaller percentage were cell associated 
proteins (22%) (Figure 3F). Of the most abundant proteins in GnHCl and RapiGestTM extraction, 65% 
and 35% were ECM and cellular associated proteins respectively (Figure 3G). The most abundant 
proteins in the GnHCl followed by RapiGestTM extract were classified as 44% ECM associated, 44% 
cellular associated and the remaining 12% were membrane associated proteins (Figure 3H).     
3.3  Quantitative differences in protein composition were observed between the 
GnHCl and GnHCl followed by RapiGest extraction methods 
Subsequent relative protein abundance between GnHCl and GnHCl followed by RapiGestTM was 
assessed by LF quantitative analysis. There were 35 differentially abundant proteins identified with 2 
or more peptides, a p-value < 0.05, and more than a 2-fold change (Figure 4A). Collagens, such as 
collagen type I alpha 2 chain, collagen type II alpha 1 chain and collagen type V alpha 1, were most 
abundantly found in the GnHCl followed by RapiGestTM extraction (Table 1). On the other hand, 
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proteoglycans, such as fibromodulin and lumican, were most abundantly found after GnHCl 
extraction (Table 1). Several cellular proteins, such as actin 1 and 4, talin 1, and tubulin alpha 4A, 
were also found to be more abundant after GnHCl extraction. Following GnHCl extraction, the 
collagenous proteins and the proteoglycans abundance represented 49% and 20% respectively of 
the overall identified proteins abundance. Whereas GnHCl followed by RapiGestTM extraction 
resulted in 80% and 4% abundance of collagens and proteoglycans respectively (Supplementary 
Table 3).  
The addition of RapiGestTM at variable concentrations (0.1%, 0.2% and 0.4%) following GnHCl 
extraction demonstrated no differences on 1D SDS-PAGE analysis between the three concentrations 
indicating the use of 0.1% RapiGestTM on the insoluble pellet is sufficient (Figure 4B).  
4 4 Discussion  
This is the first study to compare different protein extraction methods in tendon for shotgun MS. 
The experimental design involved a proteomics comparison between GnHCl, urea, and RapigestTM 
extractions and a further comparison between GnHCl and RapigestTM and their combinations.  
Both GnHCl and urea are chaotropic agents implying that they disrupt the non-covalent bonds within 
the proteins tertiary structure. In this study, we found GnHCl extraction increased the number of 
proteins identified compared to urea.  The higher number of intracellular proteins extracted with 
GnHCl indicates that this agent is able to disrupt cellular membranes in a more efficient manner, 
which is consistent with other studies findings, whereas GnHCl was thought to disrupt the cell 
membrane causing permeabilisation [34, 35]. In tendon, the relatively poorer protein identification 
by urea could possibly be due to its lower ability to solubilise the lipid bilayer of membranes which 
could lead to reduced release of cell contents and fewer less abundant proteins.  
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The surfactant RapigestTM was chosen for the detergent-based extraction method, as it does not 
supress peptide ionisation or modify peptides and proteins making it compatible with MS [36] also 
offering a simple extraction method for tendon tissue. In this study, when compared to GnHCl and 
urea, RapiGestTM gave less overall protein identifications but had fewer proteins in common with the 
chaotropic agents suggesting extraction of different proteins. RapiGestTM has been shown to 
improve ECM MS protein coverage by its addition to the trypsin digestion solution and protein 
extraction efficiency in cartilage [25, 37]. Based on the above findings, combinations of GnHCl and 
RapiGestTM extraction were further investigated in the current study.  
Overall, GnHCl and GnHCl followed by RapiGestTM demonstrated a more robust extraction of tendon 
by yielding a higher protein concentration, more protein identifications and a good representation of 
cell and membrane associated proteins. In addition, GnHCl followed by RapiGest™ demonstrated the 
least inter-sample variation in terms of protein concentration and in peptide and protein 
identification and quantification, suggesting this method to be the most consistent.  
Furthermore, the addition of RapiGestTM to GnHCl extraction and RapiGestTM alone resulted in an 
increased abundance of identified collagens compared to GnHCl alone. Following GnHCl extraction, 
the proteoglycans abundance represented 20% of the overall identified protein abundance, whilst 
with GnHCl followed by RapiGestTM extraction it was only 4% and 80% were collagens compared to 
only 49% collagen proteins in GnHCl extraction.  Since tendon ECM composition consists of 60-85% 
collagens and 1-5% proteoglycans (per dry weight tissue), GnHCl followed by RapiGestTM extraction 
most closely reflected the expected tendon ECM composition [38]. These results thus demonstrate 
the advantages of combining the surfactant RapiGestTM to GnHCl extraction. However, for studies 
specifically looking at proteoglycans or less abundant proteins in tendon, GnHCl extraction may be 
more advantageous. Also for studies that are trying achieve to complete tendon proteome 
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indentification, separate MS analysis of successive fractions of GnHCl followed by RapigestTM method 
could provide more identifications. In addition, the tendon has different anatomical compartments 
with distinct proteome composition [12] and studies looking at a specific compartment such as the 
interfascicular matrix  [12]  might benefit from one method over the other.  
In our study, elastin was not identified following any of the extraction methods used. This may be 
due to elastin being highly cross-linked, hydrophobic [39] and containing repetitive sequences [40]. 
In order to identify elastin, other mass spectrometry studies have used cyanogen bromide extraction 
[41] and elastase digestion [20, 40] or 2D separation techniques which could be applied in future 
studies.  
In conclusion, we have shown for the first time a comparison between different extraction methods 
for MS analysis in tendon tissue. Whilst GnHCl followed by RapiGestTM extraction may be appropriate 
for extraction and identification of collagenous proteins, GnHCl extraction may be more appropriate 
for extraction and indentification of cellular proteins and proteoglycans in tendon tissue. Therefore, 
the optimal extraction method should be based on the hypothesis and study design. Our findings 
make a significant contribution in the field of tendon proteomics and will be invaluable for future 
studies in tendon research, and could benefit in the diagnosis and therapeutics of tendon disease.  
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Table 1. A select number of significantly differentially abundant ECM proteins identified between 
GnHCl and GnHCl followed by RapiGest extraction by ProgenesisQI LC-MS software (>2-fold change, p 
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Collagen type I alpha 2 
Collagen type I alpha 1 
Collagen type II alpha 1 
Collagen type III alpha 1 
Collagen type IV alpha   1 
Collagen type IV alpha 2 
Collagen type V alpha 1 
Collagen type V alpha 2 
Collagen type V alpha 3 
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Figure legends  
Figure 1. (A) Venn diagram of GnHCl, urea, and RapiGestTM extraction methods. Total number, 
common, and unique proteins identified following MS. All identified proteins in each method are can 
be found in Supplementary Table 1.  (B) Schematic workflow of follow up experiment using the 
chaotropic agent GnHCl, the surfactant RapiGestTM, a combination of GnHCl and RapiGestTM, and a 
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Figure 2. (A) 1D SDS-PAGE analysis of the protein profiles of GnHCl, RapiGestTM, GnHCl and 
RapiGestTM ,and GnHCl followed by RapiGestTM extraction methods. (B) Protein concentration yielded 
with the different extraction methods. Values are mean and error bars represent SD, *p < 0.05. (C) 
Venn diagram of the different extraction methods. (D) Classification of identified proteins for each 
extraction according to cell compartment (PANTHER) and matrisome classifcation (Matrisome 
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Figure 3.  (A-C) Quality control and label free quantitative analysis comparison between GnHCl, 
RapiGestTM, GnHCl and RapigestTM, and GnHCl followed by RapiGestTM using ProgenesisQI software. 
The variation in percentage of all peptide ions (A), number of peptides (B) and proteins (C) was 
presented for each extraction method. (D) PCA plot of all methods, GnHCl followed by RapiGestTM 
samples grouped closer together.  (E-H) Significantly abundant proteins (fold change > 2 and p < 
0.05) identified in GnHCl (E), RapiGest (F), GnHCl and RapiGestTM (G), and GnHCl followed by 
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Figure 4. (A) The volcano plot demonstrates all differentially abundant proteins between GnHCl and 
GnHCl followed by RapiGestTM (fold change > 2 and p < 0.05).  Collagens were most abundantly 
identified in GnHCl followed by RapiGestTM  and proteoglycans in GnHCl extraction. All differentially 
abundant proteins between GnHCl and GnHCl followed by RapiGestTM can be found in 
Supplementary table 3. (B) 1D SDS-PAGE analysis of GnHCl followed by different concentrations of 
RapiGestTM. 
 
 
 
